The groundbreaking decision is a win for harm reduction, though it also highlights absurd contradictions in the FDA's overall ...

Report with market evolution powered by AI - The global nicotine patch market size is estimated to grow by USD 494.1 million ...

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

The drug offers a non-addictive alternative to opioids, marking 'an important public health milestone in acute pain ...